CSF2 and Decreased total leukocyte count: (3) The expert panel did not recommend recombinant GM-CSF for immunomodulatory therapy in septic patients with immunosuppression, but the symptomatic treatment can be considered for sepsis patients with leukopenia (no recommendation, very good consistency).